List of Figures
Figure 1: Number of Products under Development for Asthma
Figure 2: Number of Products under Development by Companies, Asthma
Figure 3: Number of Products under Development by Universities/Institutes, Asthma
Figure 4: Number of Products under Development for Chronic Obstructive Pulmonary Disease (COPD
Figure 5: Number of Products under Development by Companies, Chronic Obstructive Pulmonary Disease (COPD)
Figure 6: Number of Products under Development by Universities/Institutes, Chronic Obstructive Pulmonary Disease (COPD)
Figure 7: Number of Products under Development for Idiopathic Pulmonary Fibrosis
Figure 8: Number of Products under Development by Companies, Idiopathic Pulmonary Fibrosis
Figure 9: Number of Products under Development by Universities/Institutes, Idiopathic Pulmonary Fibrosis
Figure 10: Number of Products by Top 10 Targets, Asthma
Figure 11: Number of Products by Stage and Top 10 Targets, Asthma
Figure 12: Number of Products by Top 10 Mechanism of Actions, Asthma
Figure 13: Number of Products by Stage and Top 10 Mechanism of Actions, Asthma
Figure 14: Number of Products by Top 10 Routes of Administration, Asthma
Figure 15: Number of Products by Stage and Top 10 Routes of Administration, Asthma
Figure 16: Number of Products by Top 10 Molecule Types, Asthma
Figure 17: Number of Products by Stage and Top 10 Molecule Types, Asthma
Figure 18: Number of Products by Top 10 Targets, Chronic Obstructive Pulmonary Disease (COPD)
Figure 19: Number of Products by Stage and Top 10 Targets, Chronic Obstructive Pulmonary Disease (COPD)
Figure 20: Number of Products by Top 10 Mechanism of Actions, Chronic Obstructive Pulmonary Disease (COPD)
Figure 21: Number of Products by Stage and Top 10 Mechanism of Actions, Chronic Obstructive Pulmonary Disease (COPD)
Figure 22: Number of Products by Top 10 Routes of Administration, Chronic Obstructive Pulmonary Disease (COPD)
Figure 23: Number of Products by Stage and Top 10 Routes of Administration, Chronic Obstructive Pulmonary Disease (COPD)
Figure 24: Number of Products by Top 10 Molecule Types, Chronic Obstructive Pulmonary Disease (COPD)
Figure 25: Number of Products by Stage and Top 10 Molecule Types, Chronic Obstructive Pulmonary Disease (COPD)
Figure 26: Number of Products by Top 10 Targets, Idiopathic Pulmonary Fibrosis
Figure 27: Number of Products by Stage and Top 10 Targets, Idiopathic Pulmonary Fibrosis
Figure 28: Number of Products by Top 10 Mechanism of Actions, Idiopathic Pulmonary Fibrosis
Figure 29: Number of Products by Stage and Top 10 Mechanism of Actions, Idiopathic Pulmonary Fibrosis
Figure 30: Number of Products by Routes of Administration, Idiopathic Pulmonary Fibrosis
Figure 31: Number of Products by Stage and Routes of Administration, Idiopathic Pulmonary Fibrosis
Figure 32: Number of Products by Top 10 Molecule Types, Idiopathic Pulmonary Fibrosis
Figure 33: Number of Products by Stage and Top 10 Molecule Types, Idiopathic Pulmonary Fibrosis